You just read:

New ALS Device Trial; the PARADIGM Study Will Continue Research of the NeuRx® Diaphragm Pacing System (DPS) in ALS Patients

News provided by

Synapse Biomedical Inc.

Oct 04, 2016, 18:52 ET